96 related articles for article (PubMed ID: 1855177)
21. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
22. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
23. Long-term depletion of naive T cells in patients treated for Hodgkin's disease.
Watanabe N; De Rosa SC; Cmelak A; Hoppe R; Herzenberg LA; Roederer M
Blood; 1997 Nov; 90(9):3662-72. PubMed ID: 9345051
[TBL] [Abstract][Full Text] [Related]
24. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
Babacan E; Cavdar AO; Arcasoy A
Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
[TBL] [Abstract][Full Text] [Related]
25. Immune recovery of lymphocyte subsets 6 years after autologous peripheral blood stem cell transplantation (PBSCT) for lymphoproliferative diseases. A comparison between NHL, HD and MM in group of 149 patients.
Laurenti L; Piccioni P; Piccirillo N; Sora' F; Chiusolo P; Garzia M; Reddiconto G; De Matteis S; Tarnani M; Leone G; Sica S
Leuk Lymphoma; 2004 Oct; 45(10):2063-70. PubMed ID: 15370251
[TBL] [Abstract][Full Text] [Related]
26. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
27. Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis.
van Rijswijk RE; de Meijer A; Sybesma JP; Kater L
Cancer; 1986 Apr; 57(8):1489-96. PubMed ID: 2936444
[TBL] [Abstract][Full Text] [Related]
28. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
Lee YT
Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.
Björkholm M; Holm G; Mellstedt H; Johansson B; Askergren J; Söderberg G
Scand J Haematol; 1977 Nov; 19(5):487-95. PubMed ID: 594663
[TBL] [Abstract][Full Text] [Related]
30. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
Romano A; Parrinello NL; Vetro C; Chiarenza A; Cerchione C; Ippolito M; Palumbo GA; Di Raimondo F
Ann Hematol; 2018 Jun; 97(6):1009-1018. PubMed ID: 29442162
[TBL] [Abstract][Full Text] [Related]
31. [The impact of CD34(+) cells and T cells subsets in grafts on prognosis of HLA-identical sibling allogeneic peripheral blood stem cell transplantation].
Zhou Z; Wang M; He Y
Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):819-23. PubMed ID: 19176036
[TBL] [Abstract][Full Text] [Related]
32. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
[TBL] [Abstract][Full Text] [Related]
33. T-cell subsets in peripheral blood of patients with newly diagnosed and posttreatment Hodgkin's and non-Hodgkin's lymphomas. Analysis by monoclonal antibody staining and flow cytometry.
De Angelis P; Kimmel M; Lacher M; Filippa D; Melamed MR
Anal Quant Cytol Histol; 1988 Aug; 10(4):235-42. PubMed ID: 2971365
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric analysis of T-lymphocytes subsets in adult Thais.
Vithayasai V; Sirisanthana T; Sakonwasun C; Suvanpiyasiri C
Asian Pac J Allergy Immunol; 1997 Sep; 15(3):141-6. PubMed ID: 9438546
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte populations in lymph nodes in different histological types of Hodgkin's disease in children.
Pituch-Noworolska A; Drabik G; Kacińska E; Klekawka T
Acta Haematol; 2004; 112(3):129-35. PubMed ID: 15345894
[TBL] [Abstract][Full Text] [Related]
36. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
37. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
38. Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Adv Otorhinolaryngol; 2005; 62():161-72. PubMed ID: 15608426
[TBL] [Abstract][Full Text] [Related]
39. Lymphocytotoxic serum factors and lymphocyte functions in untreated Hodgkin's disease.
Björkholm M; Wedelin C; Holm G; Ericsson H; Nilsson P; Mellstedt H
Cancer; 1982 Nov; 50(10):2044-8. PubMed ID: 7127249
[TBL] [Abstract][Full Text] [Related]
40. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
